BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 7559374)

  • 1. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
    Fawcett J; Kravitz HM; Zajecka JM; Schaff MR
    J Clin Psychopharmacol; 1991 Apr; 11(2):127-32. PubMed ID: 2056139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
    Thase ME; Frank E; Mallinger AG; Hamer T; Kupfer DJ
    J Clin Psychiatry; 1992 Jan; 53(1):5-11. PubMed ID: 1737741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of bipolar depression and mania.
    Cookson JC
    Br J Hosp Med; 1985 Sep; 34(3):172-5. PubMed ID: 2865999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar depression: treatment options.
    Yatham LN; Kusumakar V; Parikh SV; Haslam DR; Matte R; Sharma V; Kennedy S
    Can J Psychiatry; 1997 Aug; 42 Suppl 2():87S-91S. PubMed ID: 9288441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment.
    Arana GW; Santos AB; Knax EP; Ballenger JC
    J Clin Psychiatry; 1989 Sep; 50(9):356-7. PubMed ID: 2768205
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological relationships between mania and melancholia.
    Post RM; Uhde TW
    Encephale; 1982; 8(2):213-28. PubMed ID: 6179764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-tryptophan in depression.
    Farkas T; Dunner DL; Fieve RR
    Biol Psychiatry; 1976 Jun; 11(3):295-302. PubMed ID: 779855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid antidepressant effect of addition of lithium to tranylcypromine.
    Tariot PN; Murphy DL; Sunderland T; Mueller EA; Cohen RM
    J Clin Psychopharmacol; 1986 Jun; 6(3):165-7. PubMed ID: 3711366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of lithium-tranylcypromine treatment in refractory depression.
    Price LH; Charney DS; Heninger GR
    Am J Psychiatry; 1985 May; 142(5):619-23. PubMed ID: 3920923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.